ES2083388T3 - Anticuerpos dirigidos contra proteinas y glucoproteinas del retrovirus vih-2 eho - aplicaciones para el diagnostico. - Google Patents

Anticuerpos dirigidos contra proteinas y glucoproteinas del retrovirus vih-2 eho - aplicaciones para el diagnostico.

Info

Publication number
ES2083388T3
ES2083388T3 ES89401498T ES89401498T ES2083388T3 ES 2083388 T3 ES2083388 T3 ES 2083388T3 ES 89401498 T ES89401498 T ES 89401498T ES 89401498 T ES89401498 T ES 89401498T ES 2083388 T3 ES2083388 T3 ES 2083388T3
Authority
ES
Spain
Prior art keywords
hiv
eho
directed against
glucoproteins
antibodies directed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89401498T
Other languages
English (en)
Inventor
Ara Hovanessian
Marie-Anne Rey
Anne Laurent
Bernard Krust
Denise Guetard
Luc Montagnier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur
Original Assignee
Institut Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Institut Pasteur filed Critical Institut Pasteur
Application granted granted Critical
Publication of ES2083388T3 publication Critical patent/ES2083388T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/10—RNA viruses
    • C07K16/112—Retroviridae (F), e.g. leukemia viruses
    • C07K16/114—Lentivirus (G), e.g. human immunodeficiency virus [HIV], feline immunodeficiency virus [FIV] or simian immunodeficiency virus [SIV]
    • C07K16/1145—Env proteins, e.g. gp41, gp110/120, gp160, V3, principal neutralising domain [PND] or CD4-binding site
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION CONCIERNE A ANTIGENO PURIFICADO DEL RETROVIRUS VIH-2 EHO, O A PARTE DE DICHO ANTIGENO, O A UN ANTIGENO QUE TENGA LAS MISMAS PROPIEDADES INMUNOLOGICAS, CARACTERIZADO POR QUE EL ES UN CONSTITUYENTE PARA EL DESARROLLO DE LA GLICOPROTEINA DE VIH-2 EHO O DE UNA GLICOPROTEINA DE UNA VARIANTE DE ELLA, CONTANDO CON QUE SEA RECONOCIDO SERO POSITIVO VIH-2 HUMANO POR ENSAYO DE INMUNOPRECIPITACION, O ENSAYO DE MANCHA OCCIDENTAL Y QUE NO SEA RECONOCIDO POR ANTICUERPOS DIRIGIDOS CONTRA LA GLICOPROTEINA GP300 DE VIH-2 ROD, MEDIANTE ENSAYOS DE INMUNOPRECIPITACION, O ENSAYOS DE MANCHA OCCIDENTAL, EN LAS MISMAS CONDICIONES. TAMBIEN SE PROVEEN ANTICUERPOS CONTRA ESTOS ANTIGENOS Y MEDIOS PARA LA DIAGNOSIS DE UNA INFECCION DEBIDA A VIH-2 EHO O A ALGO RELACIONADO CON VIH-2 AISLADO.
ES89401498T 1989-05-31 1989-05-31 Anticuerpos dirigidos contra proteinas y glucoproteinas del retrovirus vih-2 eho - aplicaciones para el diagnostico. Expired - Lifetime ES2083388T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP89401498A EP0400245B1 (en) 1989-05-31 1989-05-31 Proteins and glycoproteins of the HIV-2 EHO retrovirus antibodies directed against them - application for the diagnosis

Publications (1)

Publication Number Publication Date
ES2083388T3 true ES2083388T3 (es) 1996-04-16

Family

ID=8202954

Family Applications (2)

Application Number Title Priority Date Filing Date
ES89401498T Expired - Lifetime ES2083388T3 (es) 1989-05-31 1989-05-31 Anticuerpos dirigidos contra proteinas y glucoproteinas del retrovirus vih-2 eho - aplicaciones para el diagnostico.
ES95108885T Expired - Lifetime ES2110283T3 (es) 1989-05-31 1989-05-31 Proteinas y glicoproteinas de anticuerpos de los retrovirus hiv-2 eho dirigidos contra ellos - aplicacion para la diagnosis.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES95108885T Expired - Lifetime ES2110283T3 (es) 1989-05-31 1989-05-31 Proteinas y glicoproteinas de anticuerpos de los retrovirus hiv-2 eho dirigidos contra ellos - aplicacion para la diagnosis.

Country Status (6)

Country Link
EP (2) EP0400245B1 (es)
AT (1) ATE131731T1 (es)
DE (1) DE68925202T2 (es)
ES (2) ES2083388T3 (es)
GR (2) GR3018902T3 (es)
OA (1) OA10075A (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2003383A1 (en) * 1988-11-23 1990-05-23 Sushil G. Devare Synthetic dna derived recombinant hiv antigens
RU2214274C2 (ru) * 2001-08-16 2003-10-20 Государственное предприятие Институт иммунологии Федерального управления медико-биологических экстремальных проблем при МЗ РФ Иммуногенная композиция, содержащая химерный полипептид вич, полипептиды и тест-система для обнаружения антител к вич

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0239425B1 (fr) * 1986-01-22 1989-11-02 Institut Pasteur Rétrovirus du type HIV-2 susceptible de provoquer le SIDA, et ses constituants antigéniques et nucléiques
US5030714A (en) * 1986-06-23 1991-07-09 Institut Pasteur Variant of LAV viruses
JP2948823B2 (ja) * 1987-01-16 1999-09-13 アンステイテユ・パストウール ヒト免疫不全レトロウィルス（ｈｉｖ）関連抗原性ペプチド、そのウィルス感染の検出及びワクチンへの使用
SE8701765L (sv) * 1987-04-28 1988-10-29 Statens Bakteriologiska Lab Analysmetod och medel foer denna

Also Published As

Publication number Publication date
GR3026310T3 (en) 1998-06-30
EP0400245B1 (en) 1995-12-20
GR3018902T3 (en) 1996-05-31
ES2110283T3 (es) 1998-02-01
DE68925202T2 (de) 1996-06-05
OA10075A (en) 1996-12-18
ATE131731T1 (de) 1996-01-15
DE68925202D1 (de) 1996-02-01
EP0682951A1 (en) 1995-11-22
EP0400245A1 (en) 1990-12-05
EP0682951B1 (en) 1997-12-17

Similar Documents

Publication Publication Date Title
DE3750812D1 (de) Peptidzusammensetzung und Verfahren zum Nachweis von Antikörpern gegen HTLV-III.
FI902143A0 (fi) Hiv-peptider, artificiella hiv -antigener och immunobestaemningsfoerpackningar.
ATE116993T1 (de) Saponin-hilfsmittel.
ES2016426A6 (es) Un procedimiento para detectar la presencia de anticuerpos frente a virus del sida en el suero humano.
BR9500732B1 (pt) kit diagnóstico para a detecção de anticorpos contra vìrus que causam imunodeficiência.
ES2074062T3 (es) Inmunoensayo para antigenos hiv-1 que utilizan fragmentos de f(ab')2 como sonda.
ES2056817T3 (es) Transformacion de trichoderma.
BR0012569A (pt) Proteìnas de fusão fc para aumentar a imunogenicidade de antìgenos de peptìdeo e proteìna
PT83255B (pt) Polipeptidos e anticorpos, caracteristicos do polilomavirus e suas aplicacoes no diagnostico "in vitro" na pervencao e ou na luta contra as infeccoes por papilomavirus
ES2066887T3 (es) Anticuerpo monoclonal para diferenciar individuos seropositivos hiv-2 de los hiv-1.
Robert et al. Investigation of immunofluorescence cross-reactions against Trichinella spiralis by Western blot (immunoblot) analysis
ES2118939T3 (es) Peptido para el diagnostico e inmunizacion contra la infeccion con t.cruzi.
ATE182366T1 (de) Immunoassays für und monoklonale antikörper gegen prothrombin-aktivierende peptide und ihre abbauprodukte
ATE180512T1 (de) Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik
DE69529272D1 (de) MONOKLONALER ANTIKÖRPER GEGEN DAS HUMANE Mx-PROTEIN MxA
ES2053712T3 (es) Un antigeno proteico reactivo y fragmentos del mismo.
ES2083388T3 (es) Anticuerpos dirigidos contra proteinas y glucoproteinas del retrovirus vih-2 eho - aplicaciones para el diagnostico.
ES2042461T1 (es) Producto y procedimiento para el te\ido oxidativo del cabello.
KR900004935A (ko) 슈도 모나즈 아에루기노사의 지질단백질 i(ompi)
ES2081607T3 (es) Vacuna contra nematodos.
SE9602234D0 (sv) A novel diagnostic method utilizing ECP, and reagents to be used in the methods
ES2019573A4 (es) Inmunoensayo para la deteccion de (alfa)-haloacetamidas.
AR003251A1 (es) Metodo de determinacion in vitro del grado de agregacion del peptido beta a4 y metodo para la determinacion del grado de inhibicion de la agregacion delpeptido beta a4 por un compuesto que inhibe la agregacion de dicho peptido.
SU73734A1 (ru) Способ изготовлени строительных растворов, бетонов и тому подобных материалов
ES2088371B1 (es) Procedimiento para la produccion en forma recombinante de antigenos de la glicoproteina ge de herpesvirus bovino tipo 1 y su uso en la diferenciacion serologica entre animales infectados y animales vacunados.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 400245

Country of ref document: ES